RE:This morning tweetRemember the 4% clinical trial is already being sponsored by a major pharma company so once they see the results (combined with the existing info on the 2%) they could be trying to snap up the exclusive rights for the 4% formulation. Keep in mind exclusive rights = big cheque they'll have to write. And you are right there will likely be lots more announcements on the 2% as other major players want the new gold standard to replace the banned substance that was previously used in their formulations.
Plus any day the Phase I and Animal Contract news could be hitting the wires. The Phase I (if they are positive which all indications point to a big yes) alone should cause an upwards evaluation of the shareprice given the reducted risk on top of another milestone payment rolling into SBM. Then if they can announce the animal contract with two major players that should really send things into the stratosphere.
Feels like the waiting and waiting and watching management stumble their way to commercialization and revenue is finally paying off and should be an interesting ride once the wave of news hits. GLTA!!